Chemical inhibitors of Phytohemagglutinin-M operate by various mechanisms that involve direct interaction and competitive inhibition. Mannose and N-Acetylglucosamine serve as competitive inhibitors, directly binding to the carbohydrate recognition domains of Phytohemagglutinin-M. This binding inhibits the protein's hemagglutinating activity, which is typically facilitated by the interaction of these domains with specific carbohydrates on cell surfaces. Similarly, Methyl alpha-D-mannopyranoside and Methyl alpha-D-glucopyranoside exhibit their inhibitory effects by competing with natural ligands for the binding to Phytohemagglutinin-M. These compounds mimic the structure of the protein's natural ligands, thereby blocking the agglutination function of Phytohemagglutinin-M.
Moreover, Castanospermine, Deoxymannojirimycin, Deoxynojirimycin, Swainsonine, Kifunensine, 1-Deoxynojirimycin, Isofagomine, and 2-Deoxy-D-glucose are inhibitors that structurally resemble the oligosaccharides Phytohemagglutinin-M typically binds. Their action prevents the successful interaction of Phytohemagglutinin-M with glycoprotein receptors on the cell surface, thus hindering the protein's biological activity. They achieve this by occupying the binding sites on Phytohemagglutinin-M, creating a blockade that stops the protein from agglutinating red blood cells. These inhibitors effectively inhibit the lectin domain of Phytohemagglutinin-M responsible for carbohydrate recognition, ensuring that the protein cannot perform its function of clumping together cells, which is a critical aspect of its activity in biological systems.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D-Mannose | 3458-28-4 | sc-211180 sc-211180A | 100 g 250 g | $101.00 $158.00 | 1 | |
Mannose binds to Phytohemagglutinin-M, inhibiting its hemagglutinating activity by occupying the binding sites for the carbohydrates that Phytohemagglutinin-M normally binds to on cell surfaces. | ||||||
N-Acetyl-D-glucosamine | 7512-17-6 | sc-286377 sc-286377B sc-286377A | 50 g 100 g 250 g | $92.00 $159.00 $300.00 | 1 | |
N-Acetylglucosamine can act as a competitive inhibitor to Phytohemagglutinin-M by preventing the binding of the protein to its natural ligands, thereby inhibiting its agglutinating activity. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $180.00 $620.00 | 10 | |
Castanospermine inhibits Phytohemagglutinin-M by binding to its carbohydrate recognition domain, preventing the interaction with its natural carbohydrate ligands. | ||||||
Deoxymannojirimycin hydrochloride | 84444-90-6 | sc-201360 sc-201360A | 1 mg 5 mg | $93.00 $239.00 | 2 | |
Deoxymannojirimycin binds to the carbohydrate recognition sites on Phytohemagglutinin-M, thus inhibiting its ability to agglutinate cells by blocking ligand binding. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $135.00 $246.00 $619.00 $799.00 $1796.00 | 6 | |
Swainsonine inhibits Phytohemagglutinin-M by mimicking the structure of oligosaccharides that Phytohemagglutinin-M binds to, thereby blocking its agglutination activity. | ||||||
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $132.00 $529.00 $1005.00 $6125.00 | 25 | |
Kifunensine acts as an inhibitor to Phytohemagglutinin-M by binding to its lectin domain, which is responsible for carbohydrate recognition, hindering its normal function. | ||||||
Isofagomine D-Tartrate | 957230-65-8 | sc-207767 sc-207767A sc-207767C sc-207767B | 5 mg 10 mg 50 mg 25 mg | $379.00 $710.00 $1975.00 $1199.00 | ||
Isofagomine inhibits Phytohemagglutinin-M by resembling the natural carbohydrates that Phytohemagglutinin-M would typically bind, thus hampering its biological activity. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
2-Deoxy-D-glucose inhibits Phytohemagglutinin-M by acting as a structural analog of glucose and competing with binding sites on the protein, impeding its agglutination capability. | ||||||